Summary
- Current Price
- As of today, LLY price is $1,148.84, down -0.53% on
- Current Price All-Time High
- LLY price is currently -8.05% below its historical high of $1,249.45 set on
- Market Cap
- LLY current market cap is $1,024B, up +41.93% over the past 365 days
- PE Ratio
- LLY current PE ratio is 41.35
- Revenue
- LLY current annual revenue is $65.18B, up +44.70% year-over-year
- Next Earnings
- The next earnings release for LLY is on
Profile
| Metric | Value |
|---|---|
| Full Name | Eli Lilly and Company |
| Ticker | NYSE: LLY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | lilly.com |
| Employees | 47,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1,148.84 | |
| Price, 1D Change | -0.53% | |
| Market Cap | $1,024B | |
| TTM Dividend Yield | 0.56% | |
| PE Ratio | 41.35 | |
| Beta | 0.34 | |
| Revenue | $65B | |
| Revenue, 1Y Change | +44.70% | |
| EPS | $22.95 | |
| EPS, 1Y Change | +95.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.73 | |
| Next Ex-Dividend | $1.73 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $22.95 | |
| EPS Estimate | N/A | $34.53 |
| EPS Est. Change | N/A | +50.45% |
| Revenue | $65.18B | |
| Revenue Estimate | N/A | $85.39B |
| Revenue Est. Change | N/A | +31.02% |
| Current Price | $1,148.84 | |
| Price Target | - | $1,300.00 |
| Price Tgt. Change | - | +13.16% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $12.88 | $11.71 | -9.06% | |
| $23.64 | $22.95 | -2.91% | |
| $34.53 | N/A | +50.45% | |
| $45.08 | N/A | +96.42% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $45.15B | $45.04B | -0.23% | |
| $63.84B | $65.18B | +2.09% | |
| $85.39B | N/A | +31.02% | |
| $99.09B | N/A | +52.02% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +50.70% | |
| Price, 3Y | +155.78% | |
| Market Cap, 1Y | +41.93% | |
| Market Cap, 3Y | +140.17% | |
| Revenue, 1Y | +44.70% | |
| Revenue, 3Y | +128.37% | |
| EPS, 1Y | +95.93% | |
| EPS, 3Y | +232.47% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $1,148.84 | |
| SMA 200 | $1,024.79 | |
| SMA 50 | $1,147.32 | |
| EMA 200 | $1,020.51 | |
| EMA 50 | $1,138.13 | |
| MACD | $8.85 | |
| Beta | 0.34 | |
| ATR | $36.38 | |
| 14-Day RSI | 45.78 | |
| 10-Day Volatility | 35.22% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.73 | |
| Upcoming | $1.73 | |
| Dividend Yield | 0.52% | |
| Total Dividend | $6.00 | |
| Dividends Paid | $5.38B | |
| Payout Ratio | 26.09% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $65.18B | |
| EPS | $22.95 | |
| Gross Profit | $54.62B | |
| Gross Margin | 83.79% | |
| Operating Income | $29.70B | |
| Operating Margin | 45.56% | |
| Net Income | $20.64B | |
| Net Margin | 31.67% | |
| EBITDA | $31.69B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.65 | |
| Current Ratio | 1.58 | |
| Quick Ratio | 1.19 | |
| - | ||
| Piotroski F-Score | 6 | |
| Altman Z-Score | 9.13 |
Valuations
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $26.54B | |
| Cash & Equivalents | $7.27B | |
| Total Assets | $112.48B | |
| Current Assets | $55.63B | |
| Total Liabilities | $85.94B | |
| Current Liabilities | $35.23B | |
| Total Debt | $43.87B | |
| Short Term Debt | $1.86B | |
| Accounts Payable | $5.38B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $44.54B | |
| Operating Expenses | $24.92B | |
| Cost Of Goods Sold | $10.56B | |
| SG&A | $0.00 | |
| D&A | $2.00B | |
| Interest Expense | $0.00 | |
| Income Tax | $5.09B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $16.81B | |
| CFI | -$10.97B | |
| CFF | -$2.21B | |
| Capex | $10.85B | |
| Free Cash Flow | $5.96B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| Bernstein | → | |
| UBS | → | |
| Guggenheim | → | |
| B of A Securities | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with LLY
FAQ
- What is the ticker symbol for Eli Lilly and Company?
- The ticker symbol for Eli Lilly and Company is NYSE:LLY
- Does Eli Lilly and Company pay dividends?
- Yes, Eli Lilly and Company pays dividends. The last payment was $1.73, with an ex-dividend date on May 15, 2026
- What sector is Eli Lilly and Company in?
- Eli Lilly and Company is in the Healthcare sector
- What industry is Eli Lilly and Company in?
- Eli Lilly and Company is in the General Drug Manufacturers industry
- What country is Eli Lilly and Company based in?
- Eli Lilly and Company is headquartered in United States
- When did Eli Lilly and Company go public?
- Eli Lilly and Company initial public offering (IPO) was on June 1, 1972
- Is Eli Lilly and Company in the S&P 500?
- Yes, Eli Lilly and Company is included in the S&P 500 index
- Is Eli Lilly and Company in the NASDAQ 100?
- No, Eli Lilly and Company is not included in the NASDAQ 100 index
- Is Eli Lilly and Company in the Dow Jones?
- No, Eli Lilly and Company is not included in the Dow Jones index
- When was Eli Lilly and Company last earnings report?
- Eli Lilly and Company's most recent earnings report was on April 30, 2026
- When does Eli Lilly and Company report earnings?
- The next expected earnings date for Eli Lilly and Company is August 5, 2026
Data Sources & References
- LLY Official Website www.lilly.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/59478/000005947826000013/0000059478-26-000013-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- LLY Profile on Yahoo Finance finance.yahoo.com/quote/LLY
- LLY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lly
